{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:19:41Z","timestamp":1792725581290,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cca.2026.121044","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:47:28Z","timestamp":1777535248000},"page":"121044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pentraxin-3 as a diagnostic and prognostic biomarker in inflammatory lung diseases"],"prefix":"10.1016","volume":"589","author":[{"given":"Yogendra","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avni","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya Nath","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Popat S.","family":"Kumbhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121044_bb0005","doi-asserted-by":"crossref","first-page":"1575968","DOI":"10.3389\/fimmu.2025.1575968","article-title":"Advances in understanding the role of pentraxin-3 in lung infections","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0010","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1097\/CCM.0b013e3181809aaf","article-title":"Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity","volume":"36","author":"Mauri","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2026.121044_bb0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/cclm-2012-0459","article-title":"Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia","volume":"51","author":"Kao","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/s13054-014-0562-5","article-title":"Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study","volume":"18","author":"Mauri","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2026.121044_bb0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","article-title":"The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis","volume":"10","author":"Porte","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0030","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.3390\/ijms24043537","article-title":"The prognostic value of Pentraxin-3 in COVID-19 patients: a systematic review and meta-analysis of mortality incidence","volume":"24","author":"Capra","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121044_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105213","article-title":"The long pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19","volume":"105","author":"Scavello","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2026.121044_bb0040","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2147\/COPD.S402463","article-title":"The diagnostic and assessment value of plasma pentraxin 3 in acute exacerbation of chronic obstructive pulmonary disease","volume":"18","author":"Gu","year":"2023","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.cca.2026.121044_bb0045","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.17305\/bb.2024.10875","article-title":"Serum pentraxin-3 in patients with chronic obstructive pulmonary disease: a meta-analysis","volume":"24","author":"Zhu","year":"2024","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.cca.2026.121044_bb0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1186\/s12967-025-07142-6","article-title":"A machine learning model including pentraxin-3 as predictor of outcomes in community-acquired pneumonia","volume":"23","author":"Voza","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0055","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121044_bb0060","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/eji.200324390","article-title":"Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells","volume":"33","author":"Doni","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","article-title":"Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19","volume":"22","author":"Brunetta","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0075","article-title":"Pentraxin-related protein PTX3 alleviates blast-induced acute lung injury by promoting efferocytosis to eliminate ferroptotic alveolar epithelial cells in vitro","author":"Weng","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.cca.2026.121044_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4074169","article-title":"Sequential measurements of pentraxin 3 serum levels in patients with ventilator-associated pneumonia: a nested case-control study","author":"Bilgin","year":"2018","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.cca.2026.121044_bb0085","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cmi.2018.06.015","article-title":"Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis","volume":"25","author":"Li","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cca.2026.121044_bb0090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12890-021-01793-z","article-title":"The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis","volume":"21","author":"He","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110162","article-title":"sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID","volume":"27","author":"Hurler","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.cca.2026.121044_bb0100","doi-asserted-by":"crossref","first-page":"1672485","DOI":"10.3389\/fimmu.2025.1672485","article-title":"Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3","volume":"16","author":"Kratzer","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201800117","article-title":"Admission Pentraxin-3 level predicts severity of community-acquired pneumonia independently of etiology","volume":"13","author":"Luo","year":"2019","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.cca.2026.121044_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.933960","article-title":"Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19","volume":"13","author":"Lapadula","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0115","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2025.3225","article-title":"Pentraxin-3 as a novel biomarker in predicting outcomes of nosocomial pneumonia: a prospective observational study","author":"Garg","year":"2025","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.cca.2026.121044_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hrtlng.2012.11.005","article-title":"Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity","volume":"42","author":"Lin","year":"2013","journal-title":"Heart Lung"},{"key":"10.1016\/j.cca.2026.121044_bb0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12985-024-02501-z","article-title":"Pentraxin-3 (PTX-3) as a potential biomarker for predicting death in hospitalized patients with COVID-19","volume":"21","author":"Barbosa","year":"2024","journal-title":"Virol. J."},{"key":"10.1016\/j.cca.2026.121044_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02945-24","article-title":"Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients","volume":"13","author":"Sun","year":"2025","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.cca.2026.121044_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myaf057","article-title":"Time- and temperature-dependent pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples","volume":"63","author":"Dobi\u00e1\u0161","year":"2025","journal-title":"Med. Mycol."},{"key":"10.1016\/j.cca.2026.121044_bb0140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13019-025-03544-1","article-title":"Potential auxiliary diagnostic role of pentraxin 3 in plasma and bronchoalveolar lavage fluid for pulmonary tuberculosis","volume":"20","author":"Huang","year":"2025","journal-title":"J. Cardiothorac. Surg."},{"key":"10.1016\/j.cca.2026.121044_bb0145","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4046\/trd.2013.75.6.244","article-title":"Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions","volume":"75","author":"Yeo","year":"2013","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.cca.2026.121044_bb0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.anai.2015.10.003","article-title":"Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma","volume":"115","author":"Schwingel","year":"2015","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/1354750X.2015.1118541","article-title":"Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleaners","volume":"21","author":"Casimirri","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2026.121044_bb0160","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/COPD.S123528","article-title":"Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD","volume":"12","author":"Thulborn","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.cca.2026.121044_bb0165","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/1535-7163.MCT-19-0051","article-title":"Morin inhibits proliferation and induces apoptosis by modulating the miR-188-5p\/PTEN\/AKT regulatory pathway in CML cells","volume":"18","author":"Nie","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cca.2026.121044_bb0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.ATV.0000252126.48375.d5","article-title":"Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris","volume":"27","author":"Inoue","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2026.121044_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073119","article-title":"Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome","volume":"8","author":"Bastrup-Birk","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2026.121044_bb0180","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.3390\/s140610864","article-title":"A new surface plasmon resonance-based immunoassay for rapid, reproducible and sensitive quantification of Pentraxin-3 in human plasma","volume":"14","author":"Canovi","year":"2014","journal-title":"Sensors"},{"key":"10.1016\/j.cca.2026.121044_bb0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cca.2022.09.028","article-title":"The establishment and validation of reference intervals for plasma Pentraxin-3 in healthy volunteers and patients with Takayasu's arteritis","volume":"537","author":"Zhou","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121044_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127540","article-title":"Improved accuracy in pentraxin-3 quantification assisted by aqueous biphasic systems as serum pretreatment strategies","volume":"253","author":"Mendes","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cca.2026.121044_bb0195","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.121044_bb0200","first-page":"97","article-title":"Traceability, reference systems and result comparability","volume":"28","author":"Panteghini","year":"2007","journal-title":"Clin. Biochemist. Rev."},{"key":"10.1016\/j.cca.2026.121044_bb0205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/cclm-2013-0075","article-title":"Harmonization in laboratory medicine: the complete picture","volume":"51","author":"Plebani","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002305","article-title":"A proteomics-based assessment of inflammation signatures in endotoxemia","volume":"20","author":"Burnap","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cca.2026.121044_bb0220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/labmed\/lmae111","article-title":"Pentraxin 3 stability in serum and urine samples at \u221220\u00b0C during a 4-week period","volume":"56","author":"Alfirevic","year":"2025","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/clinchem\/34.1.27","article-title":"Heterophilic antibodies: a problem for all immunoassays","volume":"34","author":"Boscato","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121044_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(02)00275-9","article-title":"Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays","volume":"325","author":"Levinson","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121044_bb0235","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/ATVBAHA.108.178947","article-title":"Associations of pentraxin 3 with cardiovascular disease and all-cause death: the cardiovascular health study","volume":"29","author":"Jenny","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2026.121044_bb0240","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.beem.2013.05.011","article-title":"Heterophilic antibody interference in immunometric assays","volume":"27","author":"Bolstad","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121044_bb0245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1515\/cclm-2022-0924","article-title":"Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays","volume":"61","author":"Karin","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0250","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/clinchem\/27.3.493","article-title":"A multi-rule Shewhart chart for quality control in clinical chemistry","volume":"27","author":"Westgard","year":"1981","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121044_bb0255","first-page":"51","article-title":"Lot-to-lot variation","volume":"39","author":"Thompson","year":"2018","journal-title":"Clin. Biochemist. Rev."},{"key":"10.1016\/j.cca.2026.121044_bb0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-8981(02)00370-4","article-title":"Specimen materials, target values and commutability for external quality assessment (proficiency testing) schemes","volume":"327","author":"Miller","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121044_bb0265","first-page":"1350","article-title":"Microfluidic device for patient-centric multiplexed assays with readout in centralized laboratories","volume":"95","author":"Hauser","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2026.121044_bb0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/joim.12411","article-title":"Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly","volume":"279","author":"Sj\u00f6berg","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0275","first-page":"21","article-title":"Using pentraxin-3 for diagnosing acute appendicitis and predicting perforation: a prospective comparative methodological study","volume":"26","author":"Gul","year":"2020","journal-title":"Ulus. Travma Acil Cerrahi Derg."},{"key":"10.1016\/j.cca.2026.121044_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.722118","article-title":"Plasma C-reactive protein and Pentraxin-3 reference intervals during normal pregnancy","volume":"12","author":"Wirestam","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0285","first-page":"807","article-title":"Reference change values","volume":"50","author":"Fraser","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0290","first-page":"8477","article-title":"Investigation of the clinical significance of detecting PTX3 for community-acquired pneumonia","volume":"24","author":"Shi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2026.121044_bb0295","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3349\/ymj.2017.58.2.370","article-title":"Long pentraxin 3 as a predictive marker of mortality in severe septic patients who received successful early goal-directed therapy","volume":"58","author":"Kim","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.cca.2026.121044_bb0300","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10753-014-0010-3","article-title":"Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease","volume":"38","author":"Kurt","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.cca.2026.121044_bb0305","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.7754\/Clin.Lab.2015.150526","article-title":"The evaluation of serum Pentraxin-3 and high-sensitivity C-reactive protein levels in patients with acute attack of COPD","volume":"61","author":"Duran","year":"2015","journal-title":"Clin. Lab."},{"key":"10.1016\/j.cca.2026.121044_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.advms.2018.08.006","article-title":"Serum levels and gene expression of pentraxin 3 are elevated in COPD","volume":"64","author":"Pozna\u0144ski","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.cca.2026.121044_bb0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.hrtlng.2024.11.010","article-title":"PTX3 (pentraxin3) is associated with lung function among people with stable-stage smoking-related chronic obstructive pulmonary disease","volume":"70","author":"Liu","year":"2025","journal-title":"Heart Lung"},{"key":"10.1016\/j.cca.2026.121044_bb0320","article-title":"Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2026.121044_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005677","article-title":"Sputum pentraxin 3 as a candidate to assess airway inflammation and remodeling in childhood asthma","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2026.121044_bb0330","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/cea.13168","article-title":"Pentraxin levels in non-eosinophilic versus eosinophilic asthma","volume":"48","author":"Gao","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cca.2026.121044_bb0335","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/cea.13364","article-title":"Pentraxin 3 and D-dimer in children with asthma: a real-world study","volume":"49","author":"Licari","year":"2019","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cca.2026.121044_bb0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.18176\/jiaci.0563","article-title":"Endothelial dysfunction and Pentraxin-3 in clinically stable adult asthma patients","volume":"31","author":"Pacholczak-Madej","year":"2021","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"10.1016\/j.cca.2026.121044_bb0345","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/biomedicines12010232","article-title":"Novel serum biomarkers for patients with allergic asthma phenotype","volume":"12","author":"Palacionyte","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121044_bb0350","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/gene.2010.41","article-title":"PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients","volume":"11","author":"Chiarini","year":"2010","journal-title":"Genes Immun."},{"key":"10.1016\/j.cca.2026.121044_bb0355","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/1753425913476741","article-title":"Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients","volume":"19","author":"Hamon","year":"2013","journal-title":"Innate Immun."},{"key":"10.1016\/j.cca.2026.121044_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106505","article-title":"Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis","volume":"185","author":"Jeong","year":"2021","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0365","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cca.2026.121044_bb0370","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10067-016-3483-7","article-title":"Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis","volume":"36","author":"\u0130lgen","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2026.121044_bb0375","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1038\/s41598-025-32619-1","article-title":"A novel, non-spirometric \"BMP index\" for predicting severe adverse outcomes in fibrosing interstitial lung diseases","volume":"16","author":"Huang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121044_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2004.09.004","article-title":"IFN-\u03b3-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in mycobacterium tuberculosis infection","volume":"7","author":"Azzurri","year":"2005","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cca.2026.121044_bb0385","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ebiom.2017.10.018","article-title":"Biomarkers of tuberculosis severity and treatment effect: a directed screen of 70 host markers in a randomized clinical trial","volume":"25","author":"Sigal","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cca.2026.121044_bb0390","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/pp-2021-0111","article-title":"Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions","volume":"6","author":"Sharma","year":"2021","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.cca.2026.121044_bb0395","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.027","article-title":"Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department","volume":"82","author":"Schirinzi","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.cca.2026.121044_bb0400","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.23199","article-title":"Pentraxin 3 as a clinical marker in children with lower respiratory tract infection","volume":"51","author":"Kim","year":"2016","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.cca.2026.121044_bb0405","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/sim.1844","article-title":"Validation and updating of predictive logistic regression models: a study on sample size and shrinkage","volume":"23","author":"Steyerberg","year":"2004","journal-title":"Stat. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0410","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0415","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121044_bb0420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2019.11.001","article-title":"Changing predictor measurement procedures affected the performance of prediction models in clinical examples","volume":"119","author":"Luijken","year":"2020","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.cca.2026.121044_bb0430","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","article-title":"Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review","volume":"22","author":"Binuya","year":"2022","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.cca.2026.121044_bb0435","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121044_bb0440","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.121044_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017653","article-title":"High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study","volume":"6","author":"Huttunen","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.cca.2026.121044_bb0450","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cca.2026.121044_bb0455","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13052-024-01735-5","article-title":"The assessment of pentraxin 3: a diagnostic and prognostic biomarker in lower respiratory tract infections in children","volume":"50","author":"Madkour","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.cca.2026.121044_bb0460","article-title":"Pentraxin-3 is a strong biomarker of sepsis severity identification and predictor of 90-day mortality in intensive care units via Sepsis 3.0 definitions","volume":"11","author":"Chen","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121044_bb0465","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13054-022-04032-x","article-title":"Pentraxin-3 as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis","volume":"26","author":"Wang","year":"2022","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2026.121044_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105507","article-title":"HL7 fast healthcare interoperability resources (HL7 FHIR) in digital healthcare ecosystems for chronic disease management: scoping review","volume":"189","author":"Gazzarata","year":"2024","journal-title":"Int. J. Med. Inform."},{"key":"10.1016\/j.cca.2026.121044_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106599","article-title":"Pentraxin-3, MyD88, GLP-1, and PD-L1: performance assessment and composite algorithmic analysis for sepsis identification","volume":"91","author":"Bauer","year":"2025","journal-title":"J. Infect."},{"key":"10.1016\/j.cca.2026.121044_bb0480","doi-asserted-by":"crossref","first-page":"32817","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long pentraxin PTX3: similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2026.121044_bb0485","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1021\/bi0607453","article-title":"Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2026.121044_bb0490","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1373\/clinchem.2017.277525","article-title":"IFCC working group recommendations for assessing commutability part 1: general experimental design","volume":"64","author":"Miller","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121044_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinbiochem.2020.10.012","article-title":"Commutability of possible external quality assessment materials for progesterone measurement","volume":"87","author":"Yi","year":"2021","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121044_bb0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2026.121044_bb0505","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.121044_bb0510","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cncy.20147","article-title":"Biospecimen reporting for improved study quality (BRISQ)","volume":"119","author":"Moore","year":"2011","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.cca.2026.121044_bb0515","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0000000000000072","article-title":"New guideline for the reporting of studies developing, validating, or updating a multivariable clinical prediction model: the TRIPOD statement","volume":"22","author":"Moons","year":"2015","journal-title":"Adv Anat Pathol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:18:01Z","timestamp":1781511481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":103,"alternative-id":["S0009898126002263"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121044","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentraxin-3 as a diagnostic and prognostic biomarker in inflammatory lung diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121044"}}